Net profit of Glaxosmithkline Pharma rose 37.53% to Rs 169.01 crore in the quarter ended March 2013 as against Rs 122.89 crore during the previous quarter ended March 2012. Sales rose 1.50% to Rs 632.14 crore in the quarter ended March 2013 as against Rs 622.78 crore during the previous quarter ended March 2012.
ParticularsQuarter EndedMar. 2013Mar. 2012% Var.Sales632.14622.78 2 OPM %26.5232.35 -18 PBDT244.58276.14 -11 PBT240.41272.02 -12 NP169.01122.89 38
Powered by Capital Market - Live News
